• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较血液透析和血液透析滤过过程中实测与动力学模型预测的磷酸盐清除率。

Comparison of measured vs kinetic-model predicted phosphate removal during hemodialysis and hemodiafiltration.

机构信息

University of Illinois at Chicago College of Medicine, Chicago, IL, USA.

出版信息

Nephrol Dial Transplant. 2022 Nov 23;37(12):2522-2527. doi: 10.1093/ndt/gfac223.

DOI:10.1093/ndt/gfac223
PMID:35869975
Abstract

BACKGROUND

To what extent hemodiafiltration (HDF) improves management of hyperphosphatemia over hemodialysis (HD) is a subject of ongoing investigation.

METHODS

We modified a previously described phosphate kinetic model to include incorporation of EUDIAL recommended equations for hemodiafiltration (HDF) clearance. We used the model to predict the recovery of phosphate from spent dialysate/hemofiltrate and compared this with averaged data from five published studies. Mean study average predialysis serum phosphate was 1.81 ± 0.20 mmol/L. Session length was close to 240 min per treatment. All HDF was done postdilution, at an average rate of 65 ± 24 mL/min.

RESULTS

Measured mean phosphate removal was 1039 ± 136 mg (33.5 ± 4.41 mmol, slightly lower than the model-predicted mean value of 1092 ± 127 mg (35.3 ± 4.09 mmol). The measured ratio of phosphate removal with HDF compared with HD averaged 1.15 ± 0.22, ranging from 1.01 to 1.44. Using mean study input parameters for patient size and treatment characteristics, the predicted ratio of phosphate removal with HDF compared with HD averaged 1.095 ± 0.029, ranging from 1.05 to 1.13.

CONCLUSIONS

Addition of EUDIAL-recommended convective clearance equations to a phosphate kinetic model predicts a 10% or greater benefit in terms of phosphate removal for HDF compared with HD at typical dialysis and hemodiafiltration treatment settings. These predictions are similar to the HDF advantage reported in the literature in studies where phosphate removal has been measured in spent dialysate.

摘要

背景

血液透析滤过(HDF)在多大程度上优于血液透析(HD)改善高磷血症的管理是一个正在研究的课题。

方法

我们修改了以前描述的磷酸盐动力学模型,纳入了 EUDIAL 推荐的血液透析滤过(HDF)清除方程。我们使用该模型预测从废弃透析液/血液滤过液中回收的磷酸盐,并将其与五项已发表研究的平均数据进行比较。平均研究平均预透析血清磷酸盐为 1.81 ± 0.20 mmol/L。治疗时间接近每次治疗 240 分钟。所有 HDF 均在后稀释下进行,平均速率为 65 ± 24 mL/min。

结果

测量的平均磷酸盐去除率为 1039 ± 136 mg(33.5 ± 4.41 mmol,略低于模型预测的 1092 ± 127 mg(35.3 ± 4.09 mmol)的平均值。HDF 与 HD 相比的磷酸盐去除率测量比值平均为 1.15 ± 0.22,范围为 1.01 至 1.44。使用患者大小和治疗特征的平均研究输入参数,HDF 与 HD 相比的磷酸盐去除预测比值平均为 1.095 ± 0.029,范围为 1.05 至 1.13。

结论

在磷酸盐动力学模型中添加 EUDIAL 推荐的对流清除方程预测,在典型的透析和血液透析滤过治疗设置下,与 HD 相比,HDF 在磷酸盐去除方面具有 10%或更高的优势。这些预测与文献中报告的 HDF 优势相似,其中在废弃透析液中测量了磷酸盐去除。

相似文献

1
Comparison of measured vs kinetic-model predicted phosphate removal during hemodialysis and hemodiafiltration.比较血液透析和血液透析滤过过程中实测与动力学模型预测的磷酸盐清除率。
Nephrol Dial Transplant. 2022 Nov 23;37(12):2522-2527. doi: 10.1093/ndt/gfac223.
2
Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.血液透析滤过——血液透析患者高磷血症的一种新治疗选择。
Clin Nephrol. 1999 Sep;52(3):152-9.
3
On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.在线血液透析滤过。β2微球蛋白清除显著。长期临床观察。
Nephrol Dial Transplant. 2000;15 Suppl 1:49-54. doi: 10.1093/oxfordjournals.ndt.a027964.
4
Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.对流对维持性血液透析患者磷清除的影响
J Ren Nutr. 2006 Jan;16(1):47-53. doi: 10.1053/j.jrn.2005.10.008.
5
A Clinical Significance of Intermittent Infusion Hemodiafiltration Using Backfiltration of Ultrapure Dialysis Fluid Compared to Hemodialysis: A Multicenter Randomized Controlled Crossover Trial.使用超纯透析液反超滤的间歇性输液血液透析滤过与血液透析的临床意义比较:一项多中心随机对照交叉试验。
Blood Purif. 2019;48(4):368-381. doi: 10.1159/000501511. Epub 2019 Jul 16.
6
High-permeability alternatives to current dialyzers performing both high-flux hemodialysis and postdilution online hemodiafiltration.替代现行透析器的高通量选择,用于进行高通量血液透析和在线后稀释血液透析滤过。
Artif Organs. 2019 Oct;43(10):1014-1021. doi: 10.1111/aor.13480. Epub 2019 Jun 18.
7
On-line hemodiafiltration with pre- and postdilution: a comparison of efficacy.前后稀释的在线血液透析滤过:疗效比较
Int J Artif Organs. 1997 Feb;20(2):81-90.
8
Clinical evaluation of internal hemodiafiltration (iHDF): a diffusive-convective technique performed with internal filtration enhanced high-flux dialyzers.内部血液透析滤过(iHDF)的临床评估:一种采用内部过滤增强型高通量透析器进行的弥散对流技术。
Int J Artif Organs. 2004 May;27(5):414-9. doi: 10.1177/039139880402700511.
9
Sodium flux during hemodialysis and hemodiafiltration treatment of acute kidney injury: Effects of dialysate and infusate sodium concentration at 140 and 145 mmol/L.急性肾损伤血液透析和血液透析滤过治疗中的钠通量:140 和 145 mmol/L 时透析液和输液中钠浓度的影响。
Artif Organs. 2023 Jun;47(6):999-1006. doi: 10.1111/aor.14487. Epub 2023 Jan 9.
10
A Randomized, Single-Blind, Crossover Trial of Recovery Time in High-Flux Hemodialysis and Hemodiafiltration.高通量血液透析与血液透析滤过恢复时间的随机、单盲、交叉试验
Am J Kidney Dis. 2017 Jun;69(6):762-770. doi: 10.1053/j.ajkd.2016.10.025. Epub 2016 Dec 23.

引用本文的文献

1
Why High-Volume Post-Dilution Hemodiafiltration Should Be the New Standard in Dialysis Care: A Comprehensive Review of Clinical Outcomes and Mechanisms.为何高容量后稀释血液滤过应成为透析治疗的新标准:临床结局与机制的全面综述
J Clin Med. 2025 Jul 9;14(14):4860. doi: 10.3390/jcm14144860.
2
High-Volume Hemodiafiltration Versus High-Flux Hemodialysis: A Narrative Review for the Clinician.高通量血液滤过与高通量血液透析:给临床医生的叙述性综述
J Clin Med. 2025 Apr 10;14(8):2614. doi: 10.3390/jcm14082614.
3
Mathematical models for phosphate kinetics in patients on maintenance hemodialysis.
维持性血液透析患者磷酸盐动力学的数学模型
Sci Rep. 2025 Mar 17;15(1):9176. doi: 10.1038/s41598-025-93443-1.
4
Kinetic Modeling Programs for Hemodialysis Adequacy Focusing on Urea, Creatinine, Phosphate, and Beta-2-Microglobulin.关注尿素、肌酐、磷酸盐和β-2-微球蛋白的血液透析充分性的动力学建模程序
Semin Dial. 2025 May-Jun;38(3):161-165. doi: 10.1111/sdi.13252. Epub 2025 Mar 11.
5
Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond.揭示高通量血液滤过的临床益处:优化中分子量尿毒症毒素及其他物质的清除
Toxins (Basel). 2023 Aug 29;15(9):531. doi: 10.3390/toxins15090531.